DK1089742T3 - Præparat til forebyggelse og/eller behandling af osteporose og forandringer forårsaget af menopause-syndrom, omfattende propionyl-L-carnitin og genistein - Google Patents

Præparat til forebyggelse og/eller behandling af osteporose og forandringer forårsaget af menopause-syndrom, omfattende propionyl-L-carnitin og genistein

Info

Publication number
DK1089742T3
DK1089742T3 DK99926749T DK99926749T DK1089742T3 DK 1089742 T3 DK1089742 T3 DK 1089742T3 DK 99926749 T DK99926749 T DK 99926749T DK 99926749 T DK99926749 T DK 99926749T DK 1089742 T3 DK1089742 T3 DK 1089742T3
Authority
DK
Denmark
Prior art keywords
porosis
genistein
carnitine
cheese
prevention
Prior art date
Application number
DK99926749T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Application granted granted Critical
Publication of DK1089742T3 publication Critical patent/DK1089742T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK99926749T 1998-06-23 1999-06-17 Præparat til forebyggelse og/eller behandling af osteporose og forandringer forårsaget af menopause-syndrom, omfattende propionyl-L-carnitin og genistein DK1089742T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000417A IT1299191B1 (it) 1998-06-23 1998-06-23 Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
PCT/IT1999/000174 WO1999066913A2 (en) 1998-06-23 1999-06-17 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein

Publications (1)

Publication Number Publication Date
DK1089742T3 true DK1089742T3 (da) 2003-03-24

Family

ID=11406005

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99926749T DK1089742T3 (da) 1998-06-23 1999-06-17 Præparat til forebyggelse og/eller behandling af osteporose og forandringer forårsaget af menopause-syndrom, omfattende propionyl-L-carnitin og genistein

Country Status (27)

Country Link
US (1) US6335038B1 (da)
EP (1) EP1089742B1 (da)
JP (1) JP4430233B2 (da)
KR (1) KR20010071541A (da)
CN (1) CN1306434A (da)
AR (1) AR018924A1 (da)
AT (1) ATE228367T1 (da)
AU (1) AU755272B2 (da)
BR (1) BR9911440A (da)
CA (1) CA2334875C (da)
DE (1) DE69904172T2 (da)
DK (1) DK1089742T3 (da)
EE (1) EE200000741A (da)
ES (1) ES2188177T3 (da)
HU (1) HU224957B1 (da)
IL (1) IL140163A0 (da)
IS (1) IS5764A (da)
IT (1) IT1299191B1 (da)
MA (1) MA26655A1 (da)
NO (1) NO20006431L (da)
NZ (1) NZ508877A (da)
PL (1) PL192118B1 (da)
PT (1) PT1089742E (da)
SK (1) SK19292000A3 (da)
TN (1) TNSN99132A1 (da)
TR (1) TR200003735T2 (da)
WO (1) WO1999066913A2 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
WO2001070212A2 (en) * 2000-03-23 2001-09-27 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of menopause
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
IT1317079B1 (it) * 2000-12-21 2003-05-26 Sigma Tau Ind Farmaceuti Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.
CA2439078C (en) * 2001-03-09 2009-08-25 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
EP1852115A1 (en) * 2001-03-15 2007-11-07 DSM IP Assets B.V. Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
AUPR957001A0 (en) * 2001-12-19 2002-01-24 Novogen Research Pty Ltd Isoflavone conjugates, derivatives thereof and therapeutic methods involving same
CN1330303C (zh) * 2002-02-15 2007-08-08 努特里奇亚有限公司 金雀异黄素在生产一种治疗骨质疏松症和肥胖症的药物中的用途 ,以及含有金雀异黄素与维生素 d和 k的组合的组合物
KR100542478B1 (ko) * 2002-08-28 2006-01-11 한경대학교 산학협력단 석류 유래 피토에스트로겐을 함유하는 건강기능식품
BRPI0314066A8 (pt) * 2002-09-09 2017-12-12 Nestec Sa Método cosmético não-terapêutico para melhorar o turgor da pele em seres humanos ou animais, ou para prevenir ou restaurar alterações relacionadas ao envelhecimento em seres humanos ou animais, e uso de uma molécula, de um antioxidante, ou de uma combinação dos mesmos, para preparação de uma composição oralmente administrável
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
KR101254454B1 (ko) * 2003-05-27 2013-04-12 디에스엠 아이피 어셋츠 비.브이. 신규한 기능식품 조성물 및 그의 용도
JP2005187454A (ja) * 2003-12-05 2005-07-14 Sankyo Co Ltd ビタミンｅ含有ｌｄｌ低下剤及び／又は動脈硬化抑制剤組成物
AU2005211165B8 (en) * 2004-01-28 2011-07-14 Nestec S.A. Nutritional composition for improving skin condition and preventing skin diseases
CN1842327B (zh) * 2004-02-03 2011-05-11 株式会社红豆杉 将源于云南红豆杉的异紫杉脂素作为成分的骨质疏松症预防、治疗药
EP1750523B1 (en) * 2004-03-17 2010-07-21 Nestec S.A. Compositions and methods for reducing or preventing obesity
CN100351248C (zh) * 2004-07-05 2007-11-28 南京大学 染料木素衍生物及其制法和用途
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
DE102004060314A1 (de) * 2004-12-08 2006-08-31 Beiersdorf Ag Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen
CN104304671A (zh) 2004-12-29 2015-01-28 希尔氏宠物营养品公司 抑制动物学习和/或记忆减退的方法
JP2008526819A (ja) * 2005-01-10 2008-07-24 ホルモス メディカル リミテッド エストロゲン欠乏に関連する症状を予防または改善するための組成物を製造するためのリグナンの使用
PL1904044T3 (pl) * 2005-07-08 2013-08-30 Sigma Tau Ind Farmaceuti Zastosowanie kombinacji obejmującej L- karnitynę lub alkanoilo-L-karnitynę, rozpuszczalny w tłuszczach benzochinon oraz wielonienasycony kwas tłuszczowy omega-3 do wytwarzania suplementu diety lub leku do leczenia chorób rogówki
US8722112B2 (en) 2005-07-14 2014-05-13 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
CN1939534B (zh) * 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
CN101365431A (zh) * 2005-10-14 2009-02-11 帝斯曼知识产权资产管理有限公司 包含白藜芦醇的营养药物组合物的新颖用途
JP2009514824A (ja) * 2005-11-02 2009-04-09 ネステク ソシエテ アノニム 雄の哺乳動物における体脂肪の蓄積を低減するためのイソフラボン組成物及びその使用方法
PL1988891T3 (pl) * 2006-02-28 2017-05-31 Nestec S.A. Kompozycje oraz sposoby wywoływania wzrostu kości i hamowania zanikania kości
EP1993579A2 (en) 2006-02-28 2008-11-26 Council of Scientific and Industrial Research A pharmaceutical composition for the prevention/treatment of bone disorders and a process for the preparation thereof
PL2004160T3 (pl) * 2006-04-12 2013-02-28 Unilever Nv Doustna kompozycja o przeciwstarzeniowym działaniu na skórę
ES2391305T3 (es) * 2006-04-12 2012-11-23 Unilever N.V. Composición oral que comprende un ácido graso poliinsaturado y ácido salicílico para obtener un efecto antiinflamatorio en la piel
EP2004161B8 (en) * 2006-04-12 2013-04-17 Unilever PLC Oral composition comprising dha and genistein for enhancing skin properties
US8680140B2 (en) * 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
US20080108696A1 (en) * 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
PL2343292T3 (pl) 2008-09-10 2015-01-30 Agc Inc Nowa pochodna prostaglandyny I<sub>2</sub>
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
EA019237B1 (ru) * 2008-11-11 2014-02-28 Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. Соединения, пригодные для лечения целлюлита
KR101158856B1 (ko) 2009-05-12 2012-06-25 한국생명공학연구원 콩잎 추출물 또는 이의 분획물을 유효성분으로 함유하는 비만, 고지혈증, 동맥경화, 지방간, 당뇨 또는 대사증후군의 예방 또는 치료용 조성물
CN102917703B (zh) * 2010-03-08 2015-08-19 科研制药株式会社 新型ep4激动剂
CA2801281C (en) * 2010-06-16 2018-07-10 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
WO2012011572A1 (ja) * 2010-07-23 2012-01-26 国立大学法人大阪大学 拡張不全型心不全治療薬
IT201700116392A1 (it) * 2018-04-03 2019-10-03 Composizione per somministrazione orale aventi benefico effetto sulla salute della donna in menopausa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1275434B (it) * 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法

Also Published As

Publication number Publication date
MA26655A1 (fr) 2004-12-20
AU755272B2 (en) 2002-12-05
WO1999066913A2 (en) 1999-12-29
CA2334875C (en) 2009-05-12
ITRM980417A1 (it) 1999-12-23
DE69904172T2 (de) 2003-08-28
KR20010071541A (ko) 2001-07-28
ITRM980417A0 (it) 1998-06-23
BR9911440A (pt) 2001-03-20
CA2334875A1 (en) 1999-12-29
PL345030A1 (en) 2001-11-19
CN1306434A (zh) 2001-08-01
NO20006431L (no) 2001-02-22
HU224957B1 (en) 2006-04-28
EP1089742A2 (en) 2001-04-11
TR200003735T2 (tr) 2001-03-21
JP4430233B2 (ja) 2010-03-10
PT1089742E (pt) 2003-04-30
EE200000741A (et) 2002-04-15
PL192118B1 (pl) 2006-09-29
EP1089742B1 (en) 2002-11-27
HUP0102879A2 (hu) 2002-03-28
AR018924A1 (es) 2001-12-12
ATE228367T1 (de) 2002-12-15
IS5764A (is) 2000-12-08
US6335038B1 (en) 2002-01-01
WO1999066913A3 (en) 2000-04-20
IT1299191B1 (it) 2000-02-29
IL140163A0 (en) 2002-02-10
TNSN99132A1 (fr) 2005-11-10
DE69904172D1 (de) 2003-01-09
NZ508877A (en) 2002-09-27
HUP0102879A3 (en) 2002-12-28
SK19292000A3 (sk) 2001-08-06
JP2002518437A (ja) 2002-06-25
NO20006431D0 (no) 2000-12-15
ES2188177T3 (es) 2003-06-16
AU4390999A (en) 2000-01-10

Similar Documents

Publication Publication Date Title
DK1089742T3 (da) Præparat til forebyggelse og/eller behandling af osteporose og forandringer forårsaget af menopause-syndrom, omfattende propionyl-L-carnitin og genistein
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DK1173431T4 (da) Fremgangsmåde til fremstilling af citalopram
DK1632234T3 (da) (S,S)-reboxetin til behandling af kronisk træthedssyndrom
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
BR9915759B1 (pt) composiÇÕes lÍquidas contendo siloxano e processos de preparaÇço dos mesmos.
NO973922L (no) Nye taxoider, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
DK1309324T3 (da) Antikonvulsive derivater egnede til behandling og forebyggelse af udvikling af type II diabetes mellitus og syndrom X
DK1143977T3 (da) 2-oxy-benzoxazinonderivater til behandling af obesitas
MXPA03001329A (es) Metodo para la preparacion de citalopram.
DK1066056T3 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, ...
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DE50002676D1 (de) Eine film-, folien- oder oblatenförmige zubereitung
DK0828019T3 (da) Sammensat vlies, fremgangsmåde til dens fremstilling og anvendelse deraf
DK199800837A (da) Anlæg til behandling af emner
NO971495L (no) Svekkede virus og fremgangsmåte til deres fremstilling
NO20013735D0 (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
DK1562577T3 (da) Acetyl-L-carnitin til forebyggelse og/eller behandling af perifere neuropatier, der induceres af anticancermidler